CFTC Files Lawsuit Against Rhode Island in Expanding Campaign Against State Prediction Market Bans Kazatomprom Reports 17 Production Surge in Third Quarter Bolstering Uranium Supply Outlook Maxim Analyst Upgrades Gilead Sciences to Buy Amid Positive Outlook Singapore Core Inflation Sees Surprise Drop in April but Looming Energy Costs Pose Risks Indian Stock Market Outlook Sensex Nifty 50 Performance Next Week Amid USIran Tensions Reddit Shares Slide Nearly 6 on Metas Launch of Competing Forum App RDIB Q3 2025 Earnings EPS Misses Estimates Amid Operational Headwinds Newmark Group Inc NMRK Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline A2Z Cust2Mate Solutions Corp AZ Q3 2025 Earnings Loss per Share of 007 as the Company Advances Retail Technology Solutions DHI Group DHX Q1 2026 Earnings EPS Crushes Estimates by 164 Stock Surges WPC Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds Schneider National SNDR Holds Near Support After Modest Gain Callaway Golf Company CALY Holds Ground With Modest Gains Key Levels in Focus ProQR Therapeutics PRQR Holds Steady Near 157 as Uplift Potential Remains Oklo Inc OKLO Shows Modest Gains as Shares Test Key Resistance Levels Adamas Trust Senior Notes ADAMI Edge Lower as Price Hovers Near Midpoint of Range NBCC Reports 3878 Profit Growth in Q4FY26 Declares Dividend of 046 SCVL Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Retail Footwear Market CPS Technologies CPSH Surges 127 on High Volume Testing Key Resistance at 552 VSEC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction KG Q3 2024 Earnings Loss Reported Amid Limited Disclosure Stock Declines LTRN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Control as RD Pipeline Advances NWE Q1 2026 Earnings EPS Beats Estimates by 691 as Utility Operations Show Stability NioCorp Q1 2026 Earnings Surprise Profitability Achieved Amid PreRevenue Stage Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response